20.04.2020 – 16:00 Cannamedical® Pharma GmbH Conducts First Closing on 12MEUR Strategic Investment Round Led by Healthcare Executive Steve Wiggins Cologne, Germany (ots) - Cannamedical® Pharma GmbH, the leading independent brand in Germany's fast-growing medical cannabis market, announced today the first closing of a new 12MEUR strategic investment round and the addition of Steve Wiggins to the Company's Board of Directors. Mr. Wiggins is one of the most ... more
09.12.2019 – 17:02 Cannamedical® provides pharmacists with CBD-kit for the formulation of medical, GMP-compliant CBD-oil Cologne (ots) - Cannamedical® Pharma GmbH, one of the leading cannabis distributors and supplier of one of the best-known medical Cannabis brands in Germany and the European Union, is now offering a GMP-certified kit for the formulation of pharmaceutical CBD-oils. With this formulation kit, Cannamedical® enables ... more